Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model
about
CarbapenemsIn vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniaeEfficacy of human-simulated exposures of tomopenem (formerly CS-023) in a murine model of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus infectionSynergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.KPC presence in Pseudomonas aeruginosa has minimal impact on the in vivo efficacy of carbapenem therapy.Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection modelIn vivo efficacy of humanized high dose meropenem and comparators against Pseudomonas aeruginosa isolates producing verona integron-encoded metallo-β-lactamase (VIM).Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms.Pharmacodynamic optimization of beta-lactams in the patient care setting.Pharmacokinetic and pharmacodynamic properties of meropenem.Characterizing in vivo pharmacodynamics of carbapenems against Acinetobacter baumannii in a murine thigh infection model to support breakpoint determinations.Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection.Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-negative Bacteria in the Murine Thigh Infection Model.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.Efficacy of humanized high-dose meropenem, cefepime, and levofloxacin against Enterobacteriaceae isolates producing Verona integron-encoded metallo-β-lactamase (VIM) in a murine thigh infection model.Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
P2860
Q28286055-A614B37C-26B6-41FE-9FB6-1E2B5D25BFBBQ34309420-E12E374E-AB58-455A-9333-C7560D7A2CE1Q35005216-BBD7FFF2-09D6-4F7E-A70A-909D8111FA75Q35364071-5D0AEC4A-FBC8-49F9-BC7B-77BA6C36BE5AQ36200010-A4DB9F8E-E4F8-42AB-A84C-CB7FF99ABB9BQ36558317-B1F00974-CF7D-4A11-A81B-776C941CADA9Q36785886-C3FE71DB-FB87-47D1-954F-37CA9CD2436FQ37036574-28D7D755-10EB-4B2A-90F2-E6828D95A118Q37097371-E1631EB4-2B19-4165-9C49-FE441DAA2049Q37119959-F7AA69A1-38BB-40BA-952D-D2B74348D885Q37169843-5D793A38-721F-4245-9CEC-5DB973989BBBQ37247125-5FE9F301-49FA-498B-AB84-D0D7F025672AQ37544407-9647133A-BA83-484A-84AC-B1B6941B02F2Q37643634-A2E994FA-E9C4-40BC-95AB-000C5DE7BCE7Q37643705-E953ECE8-11FA-4B9F-95BA-147368127231Q37771799-58EA08FD-ABED-4B64-8EE3-6911A0CF6ADFQ38605125-271D7BB2-073C-44A4-AA76-6094ED1B7D2DQ38605133-6D21D4B3-3080-4EC3-8467-F4AC859431FEQ38672016-148AF499-C44C-44A8-8796-8EEA36103B0AQ40096922-24B299D1-CC72-4504-B04E-50BD35729767Q40913492-36BC91ED-077C-48CC-9BA3-B89D814FE8F3Q40976243-BE580CB8-20C1-464A-887E-EC0FFE1A9D9FQ58774660-DDB890DE-9575-4F38-90D0-EA61CAF88E9E
P2860
Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bactericidal activities of mer ...... neutropenic mouse thigh model
@ast
Bactericidal activities of mer ...... neutropenic mouse thigh model
@en
type
label
Bactericidal activities of mer ...... neutropenic mouse thigh model
@ast
Bactericidal activities of mer ...... neutropenic mouse thigh model
@en
prefLabel
Bactericidal activities of mer ...... neutropenic mouse thigh model
@ast
Bactericidal activities of mer ...... neutropenic mouse thigh model
@en
P2093
P2860
P356
P1476
Bactericidal activities of mer ...... neutropenic mouse thigh model
@en
P2093
C Andrew DeRyke
David P Nicolau
Hong Wei Fan
Mary Anne Banevicius
P2860
P304
P356
10.1128/AAC.00752-06
P407
P577
2007-02-05T00:00:00Z